Neumora Directors Snap Up 4.65 Million Options in Bold Bet on Future Catalyst
Neumora Therapeutics sees a big insider option surge—board buys 4.65M shares, hinting at confidence in future milestones and potential upside.
2 minutes to read
Neumora Therapeutics Inc
Neumora Executives Slam Dunk Insider Buying, Betting $2.33 Stock on Brain‑Therapy Breakthroughs
Neumora’s insiders buy 4.5 M shares of stock‑options, signaling confidence in its brain‑therapy pipeline and a bullish outlook for the neuro‑pharma sector.
3 minutes to read